• Jump to main navigation
  • Jump to content
U of U Health
  • Billing & Insurance
  • MyChart
Search
  • Find A U of U Health Doctor
  • All U of U Health Services
  • All U of U Health Locations
  • For All U of U Health Patients & Visitors
    • Patient Services
      • Questions About Your Bill?
      • Urgent Care
      • Where to Stay
      • Patients & Family Services
      • Clinical Trials
    • University of Utah Hospital
      • University of Utah Hospital
      • Staying at the Hospital
      • Parking & Valet
      • Looking for Another Location?
    • General Questions
      • 801-581-2668
      • Find an Interpreter
      • About U of U Health
  • Billing & Insurance
  • MyChart
  • Search

Deborah A. Yurgelun-Todd, PhD

  • Clinical Information
  • Academic Information
  • Clinical Trials
  • Patient Resources
  • Videos & News
No Rating Available?
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the minimum.
0 out of 5 Patient Rating

Languages Spoken: English

Deborah Yurgelun-Todd, PhD, Professor and Vice Chair of Research, completed her doctorate in Psychology from Harvard University and subsequently trained at McLean Hospital and Harvard Medical School. She serves as Director of the Salt Lake City Mental Illness Research and Clinical Center (MIRECC) for the VISN 19 VA Health Care System and Director of the Salt Lake City VA Advanced Fellowship Program in Mental Illness Research and Treatment. Her training in neuroscience and psychopathology has led to the application of multimodal imaging approaches aimed at identifying neurobiological bases of major psychiatric disorders. She has received funding for her research from NIMH, NIDA, CDC, CIA, and the Department of Veterans Affairs. Her recent work has focused on understanding the neurobiologic basis of impulsivity, mood regulation and decision-making as risk factors for behavioral disorders. She served as an author on more than 250 publications and is a standing member on both NIH and VA grant review committees.

Specialties

  • Psychology

Board Certification and Academic Information

Academic Departments Psychiatry - Professor
Academic Divisions Adult Psychiatry

Deborah Yurgelun-Todd, PhD, Professor and Vice Chair of Research, completed her doctorate in Psychology from Harvard University and subsequently trained at McLean Hospital and Harvard Medical School. She serves as Director of the Salt Lake City Mental Illness Research and Clinical Center (MIRECC) for the VISN 19 VA Health Care System and Director of the Salt Lake City VA Advanced Fellowship Program in Mental Illness Research and Treatment. Her training in neuroscience and psychopathology has led to the application of multimodal imaging approaches aimed at identifying neurobiological bases of major psychiatric disorders. She has received funding for her research from NIMH, NIDA, CDC, CIA, and the Department of Veterans Affairs. Her recent work has focused on understanding the neurobiologic basis of impulsivity, mood regulation and decision-making as risk factors for behavioral disorders. She served as an author on more than 250 publications and is a standing member on both NIH and VA grant review committees.

Academic Locations

Research Statement

A. Narrative Report of Research, Teaching, and Clinical Contributions The focus of my research has been on the identification of brain abnormalities, particularly disruptions of the fronto-temporal network, which may represent risk factors for psychiatric illness or may be the site of primary pathology in these illnesses. Research studies have primarily included the application of neuropsychological measures, neurological hard signs, and magnetic resonance imaging methods completed both in patients and their well relatives. In recent years, this work has been extended by applying magnetic resonance techniques to study the effects of development on cortico-limbic networks in healthy children and adolescents. Additional ongoing studies have examined changes in these same networks produced by therapeutic antipsychotic drugs, as well as drugs of abuse. My future investigations will continue to examine the similarities and differences between functional cortical brain changes associated with pharmacotherapy of adult illness and healthy development.

Board Certification and Academic Information

Academic Departments Psychiatry - Professor
Academic Divisions Adult Psychiatry

Education History

Postdoctoral Fellowship Boston Neurobehavioral Institute

Postdoctoral Fellow, 1989
Doctoral Training Harvard University
Neuro/Psych
Ph.D., 1988
Graduate Training Harvard University
Psychology
M.A., 1986
Graduate Training Boston College
Psychology
M.A., 1979
Undergraduate Mount Holyoke College
Biology
B.A., 1974

Selected Publications - Journal Articles

Journal Article

  1. Sheth C, McGlade E, Yurgelun-Todd D (2017). Chronic Stress in Adolescents and its Neurobiological and Psychopathological Consequences: A RDoC Perspective. Chronic Stress (Thousand Oaks), 1, 1-22.
  2. Lopez-Larson MP, Shah LM, Weeks HR, King JB, Mallik AK, Yurgelun-Todd DA, Anderson JS (2017). Abnormal Functional Connectivity Between Default and Salience Networks in Pediatric Bipolar Disorder. Biol Psychiatry Cogn Neurosci Neuroimaging, 2(1), 85–93.
  3. Bermudez J, Krizaj D, Lipschitz DL, Bueler CE, Rogowska J, Yurgelun-Todd D, Nakamura Y (2016). Externally-induced meditative states: an exploratory fMRI study of architects' responses to contemplative architecture. 6(2), 123-136.
  4. Legarreta M, Bueler CE, DiMuzio D, McGlade E, Yurgelun-Todd D (2016). Pain Catastrophizing, Perceived Pain Disability, and Pain Descriptors: Their Association with Neuropsychological Performance. Prof Psychol Res Pr, 46(7), 418-426.
  5. Epstein DJ, Legarreta M, Bueler E, King J, McGlade E, Yurgelun-Todd D (2016). Orbitofrontal cortical thinning and aggression in mild traumatic brain injury patients. Brain Behav, 6(12), e00581.
  6. Subramaniam P, McGlade E, Yurgelun-Todd D (2016). Comorbid Cannabis and Tobacco Use in Adolescents and Adults. Curr Addict Rep, 3(2), 182–188.
  7. DiMuzio J, Bueler C, Hicks-Little C, Fuller A, McGlade E, Yurgelun-Todd D (2016). Orbitalfrontal Connectivity and Impulsivity Characteristics in Collegiate Football Players. Med Sci Sports Exerc, 48(5 Suppl 1), 904.
  8. Bueler E, Epstein D, Hicks-Little C, Fuller A, DiMuzio J, McGlade E, Yurgelun-Todd D (2016). Aggression and Quality of Life in Collegiate Football Players at Pre-season and One-year Follow Up. Med Sci Sports Exerc, 48(5S Suppl 1), 843.
  9. McGlade E, Bakian A, Coon H, Yurgelun-Todd D, Callor, WB, Byrd J, Gray D (2016). Male Suspected Suicide Decedents in Utah: A Comparison of Veterans and Nonveterans. Compr Psychiatry, 69, 1-10.
  10. Graham J, Legarreta M, North L, DiMuzio J, McGlade E, Yurgelun-Todd D (2016). A Preliminary Study of DSM-5 PTSD symptom Patterns in Veterans by Trauma Type. Mil Psychol, 28(2), 115-122.
  11. King J, Lopez-Larson M, Yurgelun-Todd D (2016). Mean cortical curvature reflects cytoarchitecture restructuring in mild traumatic brain injury. Neuroimage Clin, 11, 81-89.
  12. McGlade E, Rogowska J, Yurgelun-Todd D (2015). Sex differences in orbitofrontal connectivity in male and female veterans with TBI. Brain Imaging Behav, 9(3), 535-549.
  13. Baskin-Sommers AR, Hooley JM, Dahlgren MK, Gonenc A, Yurgelun-Todd DA, Gruber SA (2015). Elevated Preattentive Affective Processing in Individuals with Borderline Personality Disorder: A Preliminary fMRI Study. Front Psychol, 6.

Patent

  1. Yurgelun-Todd, D, Renshaw, P (2019). Methods and compositions for improving cognitive performance 20100041621.
  2. Yurgelun-Todd, D, Renshaw, P (2019). Methods for improving frontal brain bioenergetic metabolism 20100041620.
  3. Yurgelun-Todd, D, Renshaw, P (2015). Administration of Citicoline to Improve Cognitive Performance, Attentional Performance, and Motor Function. U.S. Patent No. PCT/IB2015/053178. Washington, D.C.:U.S. Patent and Trademark Office.
  4. Yurgelun-Todd, D, Renshaw, P (2015). Combination of Creatine, an Omega-3 Fatty Acid, and Citicoline. U.S. Patent No. PCT/US2015/014856. Washington, D.C.:U.S. Patent and Trademark Office.
  5. Yurgelun-Todd, D, Renshaw, P (2003). Use of secretin in treatments of disorders associated with the amygdala. U.S. Patent No. PCT/US2004/015282. Washington, D.C.:U.S. Patent and Trademark Office.

Cannabis (CBD) Effects of Treating People for Chronic Non-Cancer Pain

Description: Keywords: Principal Investigator: Deborah Yurgelun-Todd

Chronic Non-Cancer pain MRI research study evaluating the effects of oral cannabis on chronic pain

Description: Keywords: Principal Investigator: Deborah Yurgelun-Todd

PH94B: A Possible Medication for Social Anxiety Disorder

Description: Keywords: Principal Investigator: Deborah Yurgelun-Todd

News Articles

Marijuana and the Teen Brain

U Launches Large-Scale Study to Understand How Teens' Experiences Impact the Brain

Feature News

Studying the Pre-Adolescent Brain to Gain Insight into Mental Health Disorders

Effects of Cannabinoids in Pain Management

Unraveling the Mystery of Sleep

The Neuroscience Initiative: Studying the Brain in Health and Disease

Site Links

  • Find an Interpreter
  • About Us
  • Academics & Research
  • Billing
  • Jobs
  • Giving
  • Maps & Directions
  • Newsroom
  • Referring Providers

Helpful Links

  • Patient Rights & Responsibilities
  • Disclaimer
  • Privacy Statement
  • DNV GL Public Information Policy Statement
  • Non-Discrimination Policy
  • Surprise Billing Rights
  • Webmaster

Contact Us

University of Utah Health

50 North Medical Drive
Salt Lake City, UT 84132

801-581-2121

  • Facebook
  • Twitter
  • Youtube
  • Instagram

University of Utah

All clinical services and programs are part of University of Utah Health Hospitals and Clinics.

Copyright © 2022 University of Utah Health